The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia

Fernando, F., Innes, A. J., Claudiani, S., Pryce, A., Hayden, C., Byrne, J., Gallipoli, P., Copland, M. , Apperley, J. F. and Milojkovic, D. (2023) The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia. Bone Marrow Transplantation, 58(7), pp. 826-828. (doi: 10.1038/s41409-023-01975-9) (PMID:37015970)

Abstract

No abstract available.

• Item Type: Articles (Letter)
• Additional Information: JFA and DM are grateful for the support of the Imperial College National Institute of Health Research (NIHR) Biomedical Research Centre and Blood Cancer UK Vaccine Research Collaborative, a partnership between Blood Cancer UK, Myeloma UK, Anthony Nolan and the British Society of Haematology (Grant 21011).
• Status: Published
• Refereed: Yes
• Glasgow Author(s) Enlighten ID: Copland, Professor Mhairi
• Authors: Fernando, F., Innes, A. J., Claudiani, S., Pryce, A., Hayden, C., Byrne, J., Gallipoli, P., Copland, M., Apperley, J. F., and Milojkovic, D.
• College/School: College of Medical Veterinary and Life Sciences > School of Cancer Sciences
• Journal Name: Bone Marrow Transplantation
• Publisher: Springer Nature
• ISSN: 0268-3369
• ISSN (Online): 1476-5365
• Published Online: 04 April 2023
• Copyright Holders: Copyright © 2023 The Authors
• First Published: First published in Bone Marrow Transplantation 58(7):826-828
• Publisher Policy: Reproduced in accordance with the publisher copyright policy